Pricing Plans

Disclaimer

Botox®  is a prescription medicine  for the treatment of frown lines , horizontal forehead lines and crow’s feet round the eyes. Botox® has risks and benefits. Ask your doctor if Botox is right for you.  If you have side effects, see your doctor.  You will need to pay for Botox® and clinic fees will apply. For details on precautions & side effects consult your healthcare professional or the Consumer Medicine Information (CMI) at www.medsafe.govt.nz .  Botox® treatment lasts about 4 months and further courses of treatment may be necessary.  Should only be administered by trained medical professionals. (contains botulinum toxin A 50,100 & 200 units) Allergan (NZ) Limited, Auckland. 

Xeomin® is a Prescription Medicine containing 50, 100 units of incobotulinum Type A, purified Botulinum toxin type A complex for injection.  It is used for the treatment of frown lines on the forehead, lateral periorbital lines and horizontal forehead lines in adults. It should be administered only by trained medical professionals. Talk to your specialist about the benefits/risks of this procedure in appearance medicine. Xeomin treatment lasts about four months and further courses of treatment may be necessary. Cautions: people receiving blood thinning medicines, care at the proposed injection sites, pregnancy and lactation. Possible side effects: headache, pain, swelling or infection at injection site, local muscle weakness including drooping eye lids, lack of feeling & nausea. Treatment last for up to 4 months. You will need to pay for this medicine. Discuss with your specialist if Xeomin is right for you. For more information or for a copy of CMI please contact the NZ distributor: Merz, Sydney. Distributed by Healthcare Logistics, Auckland.

Dysport® is a prescription medicine for the treatment of frown lines, horizontal forehead lines and crow’s fee round the eyes. Dysport has risks and benefits. Ask your doctor is Dysport is right for you.   If you have side effects see your doctor.  You will need to pay for Dysport, and clinic fees will apply. For details on precautions & side effects consult your healthcare professional or the Consumer Medicine Information (CMI) at www.medsafe.govt.nz Dysport lasts about 4-6 months and further courses of treatment may be necessary. Should only be administered by trained medical professionals. Contains 500 units of clostridium botulinum Type A toxin. Galderma (NZ) Limited, Auckland.

Profhilo®, containing low & high molecular weight hyaluronic acid, is a Class III medical device for the treatment of the face and body for contours redefinition and laxity remodelling where skin laxity is a problem.   Profhilo has risks and benefits. Do not use with treatments such a laser resurfacing or medium deep skin-peeling. Caution in people on blood thinning medicines. Do not inject into inflamed areas or intravenously or intramuscularly. Possible side effects: pain and swelling at injection site. Accelagen Pty.  Ltd. Whanganui.

Profhilo® Structura is a Class III medical device containing low- and high-molecular weight hyaluronic acid. It is used for face treatment and dermal tissue repair where volume loss is present. Risks include injection site pain, itching, or swelling. Not to be used with laser resurfacing, skin peeling, or in inflamed areas.
Viscoderm® Hydrobooster is a hyaluronic acid skin booster (Class III medical device). It carries risks and benefits and should only be administered by a qualified healthcare professional. Side effects may include redness, swelling, or tenderness at the injection site.
Belotero® Revive is a Class III hyaluronic acid skin booster. Risks include temporary injection site reactions (swelling, redness, or bruising). It should not be used in areas of infection or in patients with hypersensitivity to ingredients.
Rejuran® is a polynucleotide-based injectable treatment. It has risks and benefits and should only be administered by a qualified healthcare professional. Possible side effects include redness, swelling, or tenderness at the injection site.

BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with fat below the jaws in adults.  Do not use in people allergic to this medicine, with infection at site of injection, pregnancy, and lactation.  Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/pain/swelling/numbness/redness/tingling/hardness/itching /discolouration/formation of small areas of hardness/warmth and injection site nerve injury. BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to 4 years. Allergan New Zealand Limited, Auckland.